Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1

MLA

Asgerdur Sverrisdottir, et al. Leukocyte Nadir as a Predictive Factor for Efficacy of Adjuvant Chemotherapy in Breast Cancer. Results from the Prospective Trial SBG 2000-1. July 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....894f834caf497ceaa864d4c9c0e130f4&authtype=sso&custid=ns315887.

APA

Asgerdur Sverrisdottir, Kenneth Villman, Johan Ahlgren, Henrik Lindman, Carl Blomqvist, Jonas Bergh, Paula Poikonen-Saksela, Per Edlund, Søren Cold, Martin Andersson, Lars Stenbygaard, Troels Bechmann, Bent Ejlertsen, & Lena Tennvall Nittby. (2020). Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1.

Chicago

Asgerdur Sverrisdottir, Kenneth Villman, Johan Ahlgren, Henrik Lindman, Carl Blomqvist, Jonas Bergh, Paula Poikonen-Saksela, et al. 2020. “Leukocyte Nadir as a Predictive Factor for Efficacy of Adjuvant Chemotherapy in Breast Cancer. Results from the Prospective Trial SBG 2000-1,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....894f834caf497ceaa864d4c9c0e130f4&authtype=sso&custid=ns315887.